Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Hybrid mobile health and telerehabilitation vs in-person physiotherapy for shoulder pain

Official title: Effects of Hybrid Care With M-Health and Tele Rehabilitation Versus Conventional Physiotherapy on Pain and Functional Outcomes in Patients With Sub-Acromial Pain Syndrome.

Run by Riphah International University · NCT07921160 · Data updated 2026-11-12

This study tests whether a mobile-health program, tele-rehabilitation sessions, or conventional physiotherapy can help adults with Subacromial Pain Syndrome.

More Subacromial Pain Syndrome trials

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment51 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Rawalpindi, Federal)
StatusRecruiting
StartedSeptember 30, 2026
Main results expectedMay 2027
Study endsJuly 2027
Registry record updatedNovember 6, 2026
Trial IDNCT07921160 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–45 with Subacromial Pain Syndrome and mild to moderate functional limitation suitable for conservative rehab.

Probably not a fit

Individuals with recent shoulder surgery, full-thickness rotator cuff tears, or severe comorbidities may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with Subacromial Pain Syndrome will be assigned to one of three rehabilitation methods for six weeks: a mobile-health program via Physitrack, therapist-supervised online telerehabilitation, or traditional in-person physiotherapy. Outcomes include pain, shoulder pain and disability, and range of motion measured at baseline, week 3, and week 6, plus exercise adherence and patient satisfaction. The study uses a quasi-experimental design with 51 adults aged 18–45, 17 per group. Data will inform how delivery mode influences clinical results and patient experience.

Why it matters

Potential benefit: If successful, patients may achieve similar or better pain relief and function with more flexible delivery options, potentially increasing access to care.

How similar studies have gone: Prior research has explored telehealth and mobile rehab with mixed results; this study adds a direct comparison to conventional care in SAPS.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18-45 years.

* Clinical diagnosis of Subacromial Pain Syndrome (SAPS).
* Lateral shoulder pain aggravated by overhead activities.
* At least 2 positive tests from the Neer test, Hawkins-Kennedy test, and Painful Arc test.
* Pain intensity recorded as greater than 3 on the Numeric Pain Rating Scale (NPRS).
* Subacute or chronic symptoms (duration \> 4 weeks).
* SPADI score between 20% and 70%, indicating mild to moderate functional limitation suitable for conservative rehabilitation.

Exclusion Criteria:

* History of shoulder surgery or fracture within the past 6 months.

  * Full-thickness rotator cuff tear (confirmed clinically/imaging if available).
  * Cervical radiculopathy or referred pain from the cervical spine.
  * Neurological disorders affecting upper-limb function.
  * Recent corticosteroid injection in the shoulder (\< 3 months).
  * Severe comorbidities preventing participation in exercise rehabilitation.

Where it's running

  • Pakistan Railway Hospital, Rawalpindi, Pakistan
    Rawalpindi, Federal, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.